https://www.selleckchem.com/pr....oducts/l-mimosine.ht
Similarly, segmental height loss was lower in the ACDF-CP group compared to the ACDF-CA group, in women compared to men, and in patients aged below 45 years compared to patients aged over 45 years. The implementation of ACDF-CP provided more beneficial outcomes compared to ACDF-CA with regard to lordosis correction and graft height loss. Moreover, ACDF-CP provided more favorable effects in women than in men and in patients aged below 45 years than in patients aged over 45 years. The implementation of ACDF-CP provided more beneficial
Like
Comment
Share
